| Net Cash Provided by (Used in) Operating Activities |
$34,309,000 |
USD |
-200% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$339,677,000 |
USD |
448% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,128,000 |
USD |
-102% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
483,209,225 |
shares |
15% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$462,375,000 |
USD |
134% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$96,976,000 |
USD |
23% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$101,395,000 |
USD |
26% |
Q2 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,128,000 |
USD |
-7.5% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$79,231,000 |
USD |
-48% |
Q3 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$78,229,000 |
USD |
175% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$2,110,000 |
USD |
41% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$1,745,847,000 |
USD |
48% |
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$1,479,000 |
USD |
147% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$1,828,000 |
USD |
89% |
Q3 2025 |
Q1 2026 |